The webinar conducted by Imageens ( link) focused on the role of imaging biomarkers in primary prevention of cardiovascular diseases (CVD). The webinar featured two leading speakers: Professor Alban Redheuil, head of cardiovascular radiology at La Pitié Salpêtrière, and Dr. Antonio Gallo, a lipidologist in the cardiovascular prevention unit at...
Artfun+ solution has laid the foundation for an extraordinary breakthrough – a predictive clinical decision tool named CardioInspect. This visionary solution harnesses the power of Artfun+ technology to drive accurate cardiovascular age and risk analysis. Based on the years of research and clinical validation of Artfun+, CardioInspect aims to revolutionize...
Read MoreWe are excited to announce that Artfun+, the cutting-edge medical technology developed by Imageens, has been creating a significant impact in the field of healthcare. Recently, BBC News featured a groundbreaking study highlighting the remarkable potential of Artfun+ in monitoring cardiovascular health through marathon training. Artfun+'s technology has demonstrated that...
Read MoreAdvancements in medical technology have led to groundbreaking discoveries in healthcare, and Artfun+ stands as a revolutionary breakthrough in measuring vascular aging biomarkers. Artfun+'s technology has demonstrated that following a 6-month moderate sports program and other non-therapeutic prevention programs could improve cardiovascular age by 4+ years (link to the study)....
Read More